Skip to main content
Clinical Trials/CTRI/2022/08/044954
CTRI/2022/08/044954Completed未知

A national wide CrossSectional Survey to evaluate the Knowledge,Attitude, and Practices (KAP) on Triple Combination Therapy ofRosuvastatin 10/20 mg Plus Aspirin 75 mg Plus Clopidogrel 75 mg) amongHealth Care professionals in India (KASPER). - KASPER

Dr Reddys Laboratories Ltd0 sites10 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
10